Alembic Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
829.65
-4.95 (-0.59%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 1.7 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
39.31
39.31
39.31
39.31
39.31
39.31
Share Warrants & Outstandings
Total Reserve
5,635.50
5,151.63
4,778.89
4,331.16
5,198.23
5,027.66
Shareholder's Funds
5,674.81
5,190.94
4,818.20
4,370.47
5,237.54
5,066.97
Minority Interest
-5.83
-1.42
0.00
0.00
0.00
-60.64
Long-Term Borrowings
121.92
0.00
0.00
0.00
0.00
199.89
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
121.92
0.00
0.00
0.00
0.00
199.89
Deferred Tax Assets / Liabilities
-269.61
-166.03
-169.64
-123.01
-5.88
4.21
Other Long Term Liabilities
224.94
46.77
62.88
69.23
72.14
71.54
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
152.91
124.31
109.51
106.20
95.82
85.52
Total Non-Current Liabilities
230.16
5.05
2.75
52.42
162.08
361.16
Current Liabilities
Trade Payables
835.08
879.89
735.64
679.81
706.39
668.77
Other Current Liabilities
408.61
251.02
223.65
251.19
316.51
260.19
Short Term Borrowings
1,238.93
1,195.57
430.45
635.87
629.99
299.90
Short Term Provisions
111.21
85.87
65.25
70.06
63.64
51.99
Total Current Liabilities
2,593.83
2,412.35
1,454.99
1,636.93
1,716.53
1,280.85
Total Liabilities
8,492.97
7,606.92
6,275.94
6,059.82
7,116.15
6,708.98
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
4,896.98
4,117.32
3,875.19
3,467.50
2,840.34
2,545.41
Less: Accumulated Depreciation
1,816.31
1,593.79
1,328.48
1,069.05
1,042.49
756.99
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
3,080.67
2,523.53
2,546.71
2,398.45
1,797.85
1,788.42
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
633.70
837.23
524.36
601.28
2,205.79
1,944.28
Intangible assets under development
49.70
0.00
0.00
0.00
98.44
238.25
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
140.88
127.21
93.02
96.33
118.40
49.31
Long Term Loans & Advances
15.43
31.15
33.29
53.74
34.88
36.70
Other Non Current Assets
30.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Assets
3,950.38
3,519.12
3,197.38
3,149.80
4,255.36
4,056.96
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
186.97
Inventories
2,510.64
2,288.14
1,643.54
1,475.27
1,609.70
1,486.15
Sundry Debtors
1,466.30
1,399.79
1,024.84
1,046.40
807.13
348.58
Cash and Bank
202.70
90.10
126.57
82.27
69.43
105.84
Other Current Assets
91.44
80.18
94.17
138.03
76.73
95.27
Short Term Loans and Advances
271.51
229.59
189.44
168.05
297.80
429.21
Total Current Assets
4,542.59
4,087.80
3,078.56
2,910.02
2,860.79
2,652.02
Net Current Assets (Including Current Investments)
1,948.76
1,675.45
1,623.57
1,273.09
1,144.26
1,371.17
Total Current Assets Excluding Current Investments
4,542.59
4,087.80
3,078.56
2,910.02
2,860.79
2,465.05
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
8,492.97
7,606.92
6,275.94
6,059.82
7,116.15
6,708.98
Contingent Liabilities
160.39
68.89
54.61
109.23
62.87
100.46
Total Debt
1,360.85
1,195.57
430.45
635.87
629.99
499.79
Book Value per share (adjusted)
288.72
264.1
245.14
222.36
266.47
257.8
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 13.82% vs 177.75% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 380.95% vs -25.62% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 10.52% vs 9.43% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is 10.75% vs 36.76% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 11.13% vs 32.78% in Mar 2025

Compare Balance Sheet Results of Alembic Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
39.31
0
39.31
0.00%
Share Warrants & Outstandings
Total Reserve
5,635.50
0
5,635.50
0.00%
Shareholder's Funds
5,674.81
0
5,674.81
0.00%
Minority Interest
-5.83
0
-5.83
0.00%
Long-Term Borrowings
121.92
0
121.92
0.00%
Secured Loans
0.00
0
0.00
0.00%
Unsecured Loans
121.92
0
121.92
0.00%
Deferred Tax Assets / Liabilities
-269.61
0
-269.61
0.00%
Other Long Term Liabilities
224.94
0
224.94
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
152.91
0
152.91
0.00%
Total Non-Current Liabilities
230.16
0
230.16
0.00%
Current Liabilities
Trade Payables
835.08
0
835.08
0.00%
Other Current Liabilities
408.61
0
408.61
0.00%
Short Term Borrowings
1,238.93
0
1,238.93
0.00%
Short Term Provisions
111.21
0
111.21
0.00%
Total Current Liabilities
2,593.83
0
2,593.83
0.00%
Total Liabilities
8,492.97
0
8,492.97
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
4,896.98
0
4,896.98
0.00%
Less: Accumulated Depreciation
1,816.31
0
1,816.31
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
3,080.67
0
3,080.67
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
633.70
0
633.70
0.00%
Intangible assets under development
49.70
0
49.70
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
140.88
0
140.88
0.00%
Long Term Loans & Advances
15.43
0
15.43
0.00%
Other Non Current Assets
30.00
0
30.00
0.00%
Total Non-Current Assets
3,950.38
0
3,950.38
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
2,510.64
0
2,510.64
0.00%
Sundry Debtors
1,466.30
0
1,466.30
0.00%
Cash and Bank
202.70
0
202.70
0.00%
Other Current Assets
91.44
0
91.44
0.00%
Short Term Loans and Advances
271.51
0
271.51
0.00%
Total Current Assets
4,542.59
0
4,542.59
0.00%
Net Current Assets (Including Current Investments)
1,948.76
0
1,948.76
0.00%
Total Current Assets Excluding Current Investments
4,542.59
0
4,542.59
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
8,492.97
0
8,492.97
0.00%
Contingent Liabilities
160.39
0
160.39
0.00%
Total Debt
1,360.85
0
1,360.85
0.00%
Book Value per share (adjusted)
288.72
0
288.72
0.00%
Annual - Borrowings
Borrowings 1,360.85 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 13.82% vs 177.75% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 224.94 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 380.95% vs -25.62% in Mar 2025

Annual - Fixed Assets
Fixed Assets 3,714.37 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 10.52% vs 9.43% in Mar 2025

Annual - Investments
Investments 140.88 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 10.75% vs 36.76% in Mar 2025

Annual - Current Assets
Current Assets 4,542.59 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.13% vs 32.78% in Mar 2025